A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
| Status: | Terminated |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/17/2019 |
| Start Date: | November 4, 2013 |
| End Date: | December 24, 2015 |
Phase 1b Study Of Docetaxel + Pf 03084014 In Metastatic Or Locally Recurrent/Advanced Triple Negative Breast Cancer
This study is aimed to determine the tolerability of the PF-03084014 plus docetaxel
combination in patients with advanced breast cancer. Preliminary information about the
efficacy of the combination will also be collected.
combination in patients with advanced breast cancer. Preliminary information about the
efficacy of the combination will also be collected.
Inclusion Criteria:
- Diagnosis of breast cancer with evidence of a) metastatic or b) locally
recurrent/advanced disease.
Exclusion Criteria:
- Prior treatment with a gamma secretase inhibitors or other Notch signaling inhibitors.
We found this trial at
11
sites
Barbara Ann Karmanos Cancer Institute Karmanos is based in southeast Michigan, in midtown Detroit, and...
Click here to add this to my saved trials
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials